Decreased MHC expression and negative regulation of T cells by way of increased alternative checkpoint expression, low T cell to MDS/AML cell ratio is thought to contribute to resistance to treatment, therefore effective therapies for tumor debulking and combination checkpoint blockade need further evaluation (112). The gene discussed is HLA-C; the disease is neoplasm.